The Kinase Activity of Hematopoietic Progenitor Kinase 1 Is Essential for the Regulation of T Cell Function

被引:78
作者
Hernandez, Sairy [1 ]
Qing, Jing [1 ]
Thibodeau, Rebecca Hong [1 ]
Du, Xiangnan [1 ]
Park, Summer [1 ]
Lee, Hyang-Mi [1 ]
Xu, Min [1 ]
Oh, Soyoung [1 ]
Navarro, Armando [1 ]
Roose-Girma, Meron [1 ]
Newman, Robert J. [1 ]
Warming, Soren [1 ]
Nannini, Michelle [1 ]
Sampath, Deepak [1 ]
Kim, Jeong M. [1 ]
Grogan, Jane L. [1 ]
Mellman, Ira [1 ]
机构
[1] Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA
来源
CELL REPORTS | 2018年 / 25卷 / 01期
关键词
NF-KAPPA-B; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CHRONIC VIRAL-INFECTION; CBL-B; HEMATOPOIETIC-PROGENITOR-KINASE-1; HPK1; NEGATIVE REGULATION; HUMAN CANCER; ACTIVATION; PROTEIN; PATHWAY;
D O I
10.1016/j.celrep.2018.09.012
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We examined hematopoietic protein kinase 1 (HPK1), whose reliance on scaffold versus kinase functions for negative immune cell regulation is poorly understood and critical to its assessment as a viable drug target. We identify kinase-dependent roles for HPK1 in CD8 T cells that restrict their anti-viral and anti-tumor responses by using HPK1 kinase-dead (HPK1.kd) knockin mice. Loss of HPK1 kinase function enhanced T cell receptor signaling and cytokine secretion in a T-cell-intrinsic manner. In response to chronic lymphocytic choriomeningitis virus (LCMV) infection or tumor challenge, viral clearance and tumor growth inhibition were enhanced in HPK1.kd mice, accompanied by an increase in effector CD8 T cell function. Co-blockade of PD-L1 further enhanced T effector cell function, resulting in superior anti-viral and anti-tumor immunity over single target blockade. These results identify the importance of HPK1 kinase activity in the negative regulation of CD8 effector functions, implicating its potential as a cancer immunotherapy target.
引用
收藏
页码:80 / 94
页数:15
相关论文
共 52 条
  • [1] PD-L1 on Tumor Cells Is Induced in Ascites and Promotes Peritoneal Dissemination of Ovarian Cancer through CTL Dysfunction
    Abiko, Kaoru
    Mandai, Masaki
    Hamanishi, Junzo
    Yoshioka, Yumiko
    Matsumura, Noriomi
    Baba, Tsukasa
    Yamaguchi, Ken
    Murakami, Ryusuke
    Yamamoto, Ayaka
    Kharma, Budiman
    Kosaka, Kenzo
    Konishi, Ikuo
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (06) : 1363 - 1374
  • [2] SELECTION OF GENETIC-VARIANTS OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS IN SPLEENS OF PERSISTENTLY INFECTED MICE - ROLE IN SUPPRESSION OF CYTO-TOXIC LYMPHOCYTE-T RESPONSE AND VIRAL PERSISTENCE
    AHMED, R
    SALMI, A
    BUTLER, LD
    CHILLER, JM
    OLDSTONE, MBA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (02) : 521 - 540
  • [3] Hematopoietic progenitor kinase 1 is a critical component of prostaglandin E2-mediated suppression of the anti-tumor immune response
    Alzabin, Saba
    Pyarajan, Saiju
    Yee, Herman
    Kiefer, Friedemann
    Suzuki, Akira
    Burakoff, Steven
    Sawasdikosol, Sansana
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (03) : 419 - 429
  • [4] Hematopoietic Progenitor Kinase 1 Is a Negative Regulator of Dendritic Cell Activation
    Alzabin, Saba
    Bhardwaj, Nina
    Kiefer, Friedemann
    Sawasdikosol, Sansana
    Burakoff, Steven
    [J]. JOURNAL OF IMMUNOLOGY, 2009, 182 (10) : 6187 - 6194
  • [5] PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
    Ansell, Stephen M.
    Lesokhin, Alexander M.
    Borrello, Ivan
    Halwani, Ahmad
    Scott, Emma C.
    Gutierrez, Martin
    Schuster, Stephen J.
    Millenson, Michael M.
    Cattry, Deepika
    Freeman, Gordon J.
    Rodig, Scott J.
    Chapuy, Bjoern
    Ligon, Azra H.
    Zhu, Lili
    Grosso, Joseph F.
    Kim, Su Young
    Timmerman, John M.
    Shipp, Margaret A.
    Armand, Philippe
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04) : 311 - 319
  • [6] Sustained JNK signaling by proteolytically processed HPK1 mediates IL-3 independent survival during monocytic differentiation
    Arnold, R.
    Frey, C. R.
    Mueller, W.
    Brenner, D.
    Krammer, P. H.
    Kiefer, F.
    [J]. CELL DEATH AND DIFFERENTIATION, 2007, 14 (03) : 568 - 575
  • [7] Activation of hematopoietic progenitor kinase 1 involves relocation, autophosphorylation, and transphosphorylation by protein kinase D1
    Arnold, R
    Patzak, IM
    Neuhaus, B
    Vancauwenbergh, S
    Veillette, A
    Van Lint, J
    Kiefer, F
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (06) : 2364 - 2383
  • [8] Caspase-mediated cleavage of hematopoietic progenitor kinase 1 (HPK1) converts an activator of NFκB into an inhibitor of NFκB
    Arnold, R
    Liou, J
    Drexler, HCA
    Weiss, A
    Kiefer, F
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (18) : 14675 - 14684
  • [9] Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b
    Bachmaier, K
    Krawczyk, C
    Kozieradzki, I
    Kong, YY
    Sasaki, T
    Oliveira-dos-Santos, A
    Mariathasan, S
    Bouchard, D
    Wakeham, A
    Itie, A
    Le, J
    Ohashi, PS
    Sarosi, I
    Nishina, H
    Lipkowitz, S
    Penninger, JM
    [J]. NATURE, 2000, 403 (6766) : 211 - 216
  • [10] Restoring function in exhausted CD8 T cells during chronic viral infection
    Barber, DL
    Wherry, EJ
    Masopust, D
    Zhu, BG
    Allison, JP
    Sharpe, AH
    Freeman, GJ
    Ahmed, R
    [J]. NATURE, 2006, 439 (7077) : 682 - 687